Patients have vilified colonoscopy preparation as an all-over awful process, but recent changes could improve the experience for patients.
GI & Endoscopy
Retired gastroenterologist Michael Fisher, MD, is helping allocate medical resources in his Maryland community as part of Talbot County's COVID-19 task force, according to The Star Democrat.
AbbVie completed its $63 billion acquisition of Allergan May 8, adding around $30 billion in full-year 2020 revenues.
Exact Sciences pivots to telemedicine in a COVID-19 world — 4 quotes on the company's Q1 performance
Exact Sciences posted first-quarter 2020 revenues of $347.8 million, a 114 percent year-over-year increase, but still realized a net loss of $105.7 million, or $0.71 per share.
Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of May 4-8:
Exact Sciences posted first-quarter 2020 revenues of $347.8 million, a 114 percent year-over-year increase.
The administrator of a Colorado GI practice said the practice is starting to see its elective procedure volumes return, in a May 7 article in the Greeley Tribune.
Here are six updates from gastroenterology companies and practices from the past week:
Motus GI secured a U.S. patent for its Pure-Vu System's sensing technology and suction control features.
Medicare beneficiaries may engage with a multi-target stool DNA test better than a fecal immunochemical test, according to a study debuted digitally at Digestive Disease Week 2020.
